nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.00308	CcSEcCtD
Nafarelin—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00304	0.00304	CcSEcCtD
Nafarelin—Weight increased—Progesterone—uterine cancer	0.00303	0.00303	CcSEcCtD
Nafarelin—Weight decreased—Progesterone—uterine cancer	0.00302	0.00302	CcSEcCtD
Nafarelin—Depression—Progesterone—uterine cancer	0.00296	0.00296	CcSEcCtD
Nafarelin—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00294	0.00294	CcSEcCtD
Nafarelin—Conjunctivitis—Progesterone—uterine cancer	0.00289	0.00289	CcSEcCtD
Nafarelin—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.00283	CcSEcCtD
Nafarelin—Sinusitis—Progesterone—uterine cancer	0.00279	0.00279	CcSEcCtD
Nafarelin—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.00275	CcSEcCtD
Nafarelin—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00273	CcSEcCtD
Nafarelin—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00269	CcSEcCtD
Nafarelin—Rhinitis—Progesterone—uterine cancer	0.00268	0.00268	CcSEcCtD
Nafarelin—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00266	0.00266	CcSEcCtD
Nafarelin—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00264	0.00264	CcSEcCtD
Nafarelin—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.00254	CcSEcCtD
Nafarelin—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00253	0.00253	CcSEcCtD
Nafarelin—Vaginal discharge—Epirubicin—uterine cancer	0.0025	0.0025	CcSEcCtD
Nafarelin—Rash maculo-papular—Etoposide—uterine cancer	0.00247	0.00247	CcSEcCtD
Nafarelin—Myasthenia—Epirubicin—uterine cancer	0.00242	0.00242	CcSEcCtD
Nafarelin—Alopecia—Progesterone—uterine cancer	0.00236	0.00236	CcSEcCtD
Nafarelin—Mental disorder—Progesterone—uterine cancer	0.00234	0.00234	CcSEcCtD
Nafarelin—Malnutrition—Progesterone—uterine cancer	0.00232	0.00232	CcSEcCtD
Nafarelin—Vaginal discharge—Doxorubicin—uterine cancer	0.00232	0.00232	CcSEcCtD
Nafarelin—Tension—Progesterone—uterine cancer	0.00228	0.00228	CcSEcCtD
Nafarelin—Nervousness—Progesterone—uterine cancer	0.00226	0.00226	CcSEcCtD
Nafarelin—Myasthenia—Doxorubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Nafarelin—Seborrhoeic dermatitis—Epirubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Nafarelin—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.00214	CcSEcCtD
Nafarelin—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00212	CcSEcCtD
Nafarelin—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00211	CcSEcCtD
Nafarelin—Vertigo—Progesterone—uterine cancer	0.00209	0.00209	CcSEcCtD
Nafarelin—Seborrhoeic dermatitis—Doxorubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Nafarelin—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.00207	CcSEcCtD
Nafarelin—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00206	CcSEcCtD
Nafarelin—Vaginal haemorrhage—Epirubicin—uterine cancer	0.00206	0.00206	CcSEcCtD
Nafarelin—Palpitations—Progesterone—uterine cancer	0.00205	0.00205	CcSEcCtD
Nafarelin—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00204	CcSEcCtD
Nafarelin—Convulsion—Progesterone—uterine cancer	0.00201	0.00201	CcSEcCtD
Nafarelin—Pleural effusion—Epirubicin—uterine cancer	0.00199	0.00199	CcSEcCtD
Nafarelin—Arthralgia—Progesterone—uterine cancer	0.00198	0.00198	CcSEcCtD
Nafarelin—Myalgia—Progesterone—uterine cancer	0.00198	0.00198	CcSEcCtD
Nafarelin—Chest pain—Progesterone—uterine cancer	0.00198	0.00198	CcSEcCtD
Nafarelin—Vaginal haemorrhage—Doxorubicin—uterine cancer	0.00191	0.00191	CcSEcCtD
Nafarelin—Oedema—Progesterone—uterine cancer	0.0019	0.0019	CcSEcCtD
Nafarelin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00189	CcSEcCtD
Nafarelin—Shock—Progesterone—uterine cancer	0.00187	0.00187	CcSEcCtD
Nafarelin—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00186	CcSEcCtD
Nafarelin—Pleural effusion—Doxorubicin—uterine cancer	0.00184	0.00184	CcSEcCtD
Nafarelin—Hyperhidrosis—Progesterone—uterine cancer	0.00183	0.00183	CcSEcCtD
Nafarelin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00182	CcSEcCtD
Nafarelin—Liver injury—Epirubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Nafarelin—Anorexia—Progesterone—uterine cancer	0.00181	0.00181	CcSEcCtD
Nafarelin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00179	CcSEcCtD
Nafarelin—Breast pain—Epirubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00173	0.00173	CcSEcCtD
Nafarelin—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00172	CcSEcCtD
Nafarelin—Insomnia—Progesterone—uterine cancer	0.00171	0.00171	CcSEcCtD
Nafarelin—Paraesthesia—Progesterone—uterine cancer	0.0017	0.0017	CcSEcCtD
Nafarelin—Dyspnoea—Progesterone—uterine cancer	0.00169	0.00169	CcSEcCtD
Nafarelin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00169	CcSEcCtD
Nafarelin—Liver injury—Doxorubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Nafarelin—Alopecia—Dactinomycin—uterine cancer	0.00167	0.00167	CcSEcCtD
Nafarelin—Sweating increased—Etoposide—uterine cancer	0.00166	0.00166	CcSEcCtD
Nafarelin—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00166	CcSEcCtD
Nafarelin—Oliguria—Epirubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Nafarelin—Herpes simplex—Epirubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Nafarelin—Decreased appetite—Progesterone—uterine cancer	0.00165	0.00165	CcSEcCtD
Nafarelin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Constipation—Progesterone—uterine cancer	0.00162	0.00162	CcSEcCtD
Nafarelin—Breast pain—Doxorubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00157	CcSEcCtD
Nafarelin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00155	CcSEcCtD
Nafarelin—Coordination abnormal—Epirubicin—uterine cancer	0.00155	0.00155	CcSEcCtD
Nafarelin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00154	CcSEcCtD
Nafarelin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00153	CcSEcCtD
Nafarelin—Oliguria—Doxorubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Nafarelin—Herpes simplex—Doxorubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Nafarelin—Pulmonary embolism—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Nafarelin—Urticaria—Progesterone—uterine cancer	0.00151	0.00151	CcSEcCtD
Nafarelin—Acute coronary syndrome—Etoposide—uterine cancer	0.0015	0.0015	CcSEcCtD
Nafarelin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00149	CcSEcCtD
Nafarelin—Myocardial infarction—Etoposide—uterine cancer	0.00149	0.00149	CcSEcCtD
Nafarelin—Cystitis noninfective—Epirubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Nafarelin—Cystitis—Epirubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Nafarelin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00147	CcSEcCtD
Nafarelin—Coordination abnormal—Doxorubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Nafarelin—Pulmonary embolism—Doxorubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Nafarelin—Myalgia—Dactinomycin—uterine cancer	0.0014	0.0014	CcSEcCtD
Nafarelin—Rash maculo-papular—Epirubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Nafarelin—Bladder pain—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Nafarelin—Neoplasm—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Nafarelin—Cystitis noninfective—Doxorubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Nafarelin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00136	CcSEcCtD
Nafarelin—Cystitis—Doxorubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Nafarelin—Asthenia—Progesterone—uterine cancer	0.00136	0.00136	CcSEcCtD
Nafarelin—Pruritus—Progesterone—uterine cancer	0.00134	0.00134	CcSEcCtD
Nafarelin—Oedema—Dactinomycin—uterine cancer	0.00134	0.00134	CcSEcCtD
Nafarelin—Diarrhoea—Progesterone—uterine cancer	0.0013	0.0013	CcSEcCtD
Nafarelin—Rash maculo-papular—Doxorubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Nafarelin—Anorexia—Dactinomycin—uterine cancer	0.00128	0.00128	CcSEcCtD
Nafarelin—Bladder pain—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Nafarelin—Neoplasm—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Nafarelin—Hepatic function abnormal—Epirubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Nafarelin—Dizziness—Progesterone—uterine cancer	0.00125	0.00125	CcSEcCtD
Nafarelin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00123	CcSEcCtD
Nafarelin—Eye pain—Epirubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00122	0.00122	CcSEcCtD
Nafarelin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00122	CcSEcCtD
Nafarelin—Alopecia—Etoposide—uterine cancer	0.00121	0.00121	CcSEcCtD
Nafarelin—Vomiting—Progesterone—uterine cancer	0.00121	0.00121	CcSEcCtD
Nafarelin—Rash—Progesterone—uterine cancer	0.0012	0.0012	CcSEcCtD
Nafarelin—Dermatitis—Progesterone—uterine cancer	0.00119	0.00119	CcSEcCtD
Nafarelin—Headache—Progesterone—uterine cancer	0.00119	0.00119	CcSEcCtD
Nafarelin—Hot flush—Epirubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Nafarelin—Increased appetite—Epirubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Nafarelin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00118	CcSEcCtD
Nafarelin—Menopausal symptoms—Epirubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Nafarelin—Decreased appetite—Dactinomycin—uterine cancer	0.00116	0.00116	CcSEcCtD
Nafarelin—Dysgeusia—Etoposide—uterine cancer	0.00116	0.00116	CcSEcCtD
Nafarelin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00114	CcSEcCtD
Nafarelin—Eye pain—Doxorubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Nafarelin—Cerebrovascular accident—Epirubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Nafarelin—Nausea—Progesterone—uterine cancer	0.00113	0.00113	CcSEcCtD
Nafarelin—Hot flush—Doxorubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Nafarelin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00109	CcSEcCtD
Nafarelin—Increased appetite—Doxorubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Nafarelin—Affect lability—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Nafarelin—Menopausal symptoms—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00108	CcSEcCtD
Nafarelin—Vertigo—Etoposide—uterine cancer	0.00107	0.00107	CcSEcCtD
Nafarelin—Mood swings—Epirubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Nafarelin—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Nafarelin—Convulsion—Etoposide—uterine cancer	0.00103	0.00103	CcSEcCtD
Nafarelin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00102	CcSEcCtD
Nafarelin—Dry skin—Epirubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Nafarelin—Chest pain—Etoposide—uterine cancer	0.00101	0.00101	CcSEcCtD
Nafarelin—Affect lability—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Nafarelin—Gastritis—Epirubicin—uterine cancer	0.000979	0.000979	CcSEcCtD
Nafarelin—Muscular weakness—Epirubicin—uterine cancer	0.000976	0.000976	CcSEcCtD
Nafarelin—Mood swings—Doxorubicin—uterine cancer	0.00097	0.00097	CcSEcCtD
Nafarelin—Abdominal distension—Epirubicin—uterine cancer	0.000962	0.000962	CcSEcCtD
Nafarelin—Asthenia—Dactinomycin—uterine cancer	0.000961	0.000961	CcSEcCtD
Nafarelin—Dry skin—Doxorubicin—uterine cancer	0.000938	0.000938	CcSEcCtD
Nafarelin—Hyperhidrosis—Etoposide—uterine cancer	0.000938	0.000938	CcSEcCtD
Nafarelin—Anorexia—Etoposide—uterine cancer	0.000925	0.000925	CcSEcCtD
Nafarelin—Diarrhoea—Dactinomycin—uterine cancer	0.000917	0.000917	CcSEcCtD
Nafarelin—Gastritis—Doxorubicin—uterine cancer	0.000906	0.000906	CcSEcCtD
Nafarelin—Muscular weakness—Doxorubicin—uterine cancer	0.000903	0.000903	CcSEcCtD
Nafarelin—Dysuria—Epirubicin—uterine cancer	0.000894	0.000894	CcSEcCtD
Nafarelin—Abdominal distension—Doxorubicin—uterine cancer	0.000891	0.000891	CcSEcCtD
Nafarelin—Paraesthesia—Etoposide—uterine cancer	0.000871	0.000871	CcSEcCtD
Nafarelin—Weight increased—Epirubicin—uterine cancer	0.00087	0.00087	CcSEcCtD
Nafarelin—Weight decreased—Epirubicin—uterine cancer	0.000865	0.000865	CcSEcCtD
Nafarelin—Dyspnoea—Etoposide—uterine cancer	0.000865	0.000865	CcSEcCtD
Nafarelin—Vomiting—Dactinomycin—uterine cancer	0.000852	0.000852	CcSEcCtD
Nafarelin—Rash—Dactinomycin—uterine cancer	0.000845	0.000845	CcSEcCtD
Nafarelin—Decreased appetite—Etoposide—uterine cancer	0.000843	0.000843	CcSEcCtD
Nafarelin—Constipation—Etoposide—uterine cancer	0.000829	0.000829	CcSEcCtD
Nafarelin—Conjunctivitis—Epirubicin—uterine cancer	0.000829	0.000829	CcSEcCtD
Nafarelin—Dysuria—Doxorubicin—uterine cancer	0.000827	0.000827	CcSEcCtD
Nafarelin—Weight increased—Doxorubicin—uterine cancer	0.000805	0.000805	CcSEcCtD
Nafarelin—Epistaxis—Epirubicin—uterine cancer	0.000804	0.000804	CcSEcCtD
Nafarelin—Weight decreased—Doxorubicin—uterine cancer	0.0008	0.0008	CcSEcCtD
Nafarelin—Sinusitis—Epirubicin—uterine cancer	0.0008	0.0008	CcSEcCtD
Nafarelin—Nausea—Dactinomycin—uterine cancer	0.000796	0.000796	CcSEcCtD
Nafarelin—Urticaria—Etoposide—uterine cancer	0.000771	0.000771	CcSEcCtD
Nafarelin—Rhinitis—Epirubicin—uterine cancer	0.000767	0.000767	CcSEcCtD
Nafarelin—Conjunctivitis—Doxorubicin—uterine cancer	0.000767	0.000767	CcSEcCtD
Nafarelin—Epistaxis—Doxorubicin—uterine cancer	0.000744	0.000744	CcSEcCtD
Nafarelin—Sinusitis—Doxorubicin—uterine cancer	0.00074	0.00074	CcSEcCtD
Nafarelin—Rhinitis—Doxorubicin—uterine cancer	0.00071	0.00071	CcSEcCtD
Nafarelin—Asthenia—Etoposide—uterine cancer	0.000696	0.000696	CcSEcCtD
Nafarelin—Pruritus—Etoposide—uterine cancer	0.000686	0.000686	CcSEcCtD
Nafarelin—Alopecia—Epirubicin—uterine cancer	0.000676	0.000676	CcSEcCtD
Nafarelin—Mental disorder—Epirubicin—uterine cancer	0.00067	0.00067	CcSEcCtD
Nafarelin—Malnutrition—Epirubicin—uterine cancer	0.000666	0.000666	CcSEcCtD
Nafarelin—Diarrhoea—Etoposide—uterine cancer	0.000664	0.000664	CcSEcCtD
Nafarelin—Tension—Epirubicin—uterine cancer	0.000654	0.000654	CcSEcCtD
Nafarelin—Dysgeusia—Epirubicin—uterine cancer	0.000652	0.000652	CcSEcCtD
Nafarelin—Nervousness—Epirubicin—uterine cancer	0.000647	0.000647	CcSEcCtD
Nafarelin—Dizziness—Etoposide—uterine cancer	0.000641	0.000641	CcSEcCtD
Nafarelin—Alopecia—Doxorubicin—uterine cancer	0.000626	0.000626	CcSEcCtD
Nafarelin—Mental disorder—Doxorubicin—uterine cancer	0.00062	0.00062	CcSEcCtD
Nafarelin—Vomiting—Etoposide—uterine cancer	0.000617	0.000617	CcSEcCtD
Nafarelin—Malnutrition—Doxorubicin—uterine cancer	0.000616	0.000616	CcSEcCtD
Nafarelin—Rash—Etoposide—uterine cancer	0.000612	0.000612	CcSEcCtD
Nafarelin—Dermatitis—Etoposide—uterine cancer	0.000611	0.000611	CcSEcCtD
Nafarelin—Headache—Etoposide—uterine cancer	0.000608	0.000608	CcSEcCtD
Nafarelin—Tension—Doxorubicin—uterine cancer	0.000605	0.000605	CcSEcCtD
Nafarelin—Dysgeusia—Doxorubicin—uterine cancer	0.000604	0.000604	CcSEcCtD
Nafarelin—Nervousness—Doxorubicin—uterine cancer	0.000599	0.000599	CcSEcCtD
Nafarelin—Vertigo—Epirubicin—uterine cancer	0.000599	0.000599	CcSEcCtD
Nafarelin—Palpitations—Epirubicin—uterine cancer	0.000589	0.000589	CcSEcCtD
Nafarelin—Convulsion—Epirubicin—uterine cancer	0.000577	0.000577	CcSEcCtD
Nafarelin—Nausea—Etoposide—uterine cancer	0.000576	0.000576	CcSEcCtD
Nafarelin—Chest pain—Epirubicin—uterine cancer	0.000567	0.000567	CcSEcCtD
Nafarelin—Myalgia—Epirubicin—uterine cancer	0.000567	0.000567	CcSEcCtD
Nafarelin—Arthralgia—Epirubicin—uterine cancer	0.000567	0.000567	CcSEcCtD
Nafarelin—Vertigo—Doxorubicin—uterine cancer	0.000554	0.000554	CcSEcCtD
Nafarelin—Palpitations—Doxorubicin—uterine cancer	0.000545	0.000545	CcSEcCtD
Nafarelin—Oedema—Epirubicin—uterine cancer	0.000544	0.000544	CcSEcCtD
Nafarelin—Shock—Epirubicin—uterine cancer	0.000535	0.000535	CcSEcCtD
Nafarelin—Convulsion—Doxorubicin—uterine cancer	0.000534	0.000534	CcSEcCtD
Nafarelin—Hyperhidrosis—Epirubicin—uterine cancer	0.000526	0.000526	CcSEcCtD
Nafarelin—Chest pain—Doxorubicin—uterine cancer	0.000525	0.000525	CcSEcCtD
Nafarelin—Myalgia—Doxorubicin—uterine cancer	0.000525	0.000525	CcSEcCtD
Nafarelin—Arthralgia—Doxorubicin—uterine cancer	0.000525	0.000525	CcSEcCtD
Nafarelin—Anorexia—Epirubicin—uterine cancer	0.000518	0.000518	CcSEcCtD
Nafarelin—Oedema—Doxorubicin—uterine cancer	0.000503	0.000503	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000495	0.000495	CcSEcCtD
Nafarelin—Shock—Doxorubicin—uterine cancer	0.000495	0.000495	CcSEcCtD
Nafarelin—Insomnia—Epirubicin—uterine cancer	0.000492	0.000492	CcSEcCtD
Nafarelin—Paraesthesia—Epirubicin—uterine cancer	0.000488	0.000488	CcSEcCtD
Nafarelin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000486	0.000486	CcSEcCtD
Nafarelin—Dyspnoea—Epirubicin—uterine cancer	0.000485	0.000485	CcSEcCtD
Nafarelin—Anorexia—Doxorubicin—uterine cancer	0.00048	0.00048	CcSEcCtD
Nafarelin—Decreased appetite—Epirubicin—uterine cancer	0.000473	0.000473	CcSEcCtD
Nafarelin—Constipation—Epirubicin—uterine cancer	0.000465	0.000465	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000458	0.000458	CcSEcCtD
Nafarelin—Insomnia—Doxorubicin—uterine cancer	0.000455	0.000455	CcSEcCtD
Nafarelin—Paraesthesia—Doxorubicin—uterine cancer	0.000452	0.000452	CcSEcCtD
Nafarelin—Dyspnoea—Doxorubicin—uterine cancer	0.000448	0.000448	CcSEcCtD
Nafarelin—Decreased appetite—Doxorubicin—uterine cancer	0.000437	0.000437	CcSEcCtD
Nafarelin—Urticaria—Epirubicin—uterine cancer	0.000432	0.000432	CcSEcCtD
Nafarelin—Constipation—Doxorubicin—uterine cancer	0.00043	0.00043	CcSEcCtD
Nafarelin—Urticaria—Doxorubicin—uterine cancer	0.0004	0.0004	CcSEcCtD
Nafarelin—Asthenia—Epirubicin—uterine cancer	0.00039	0.00039	CcSEcCtD
Nafarelin—Pruritus—Epirubicin—uterine cancer	0.000385	0.000385	CcSEcCtD
Nafarelin—Diarrhoea—Epirubicin—uterine cancer	0.000372	0.000372	CcSEcCtD
Nafarelin—Asthenia—Doxorubicin—uterine cancer	0.000361	0.000361	CcSEcCtD
Nafarelin—Dizziness—Epirubicin—uterine cancer	0.00036	0.00036	CcSEcCtD
Nafarelin—Pruritus—Doxorubicin—uterine cancer	0.000356	0.000356	CcSEcCtD
Nafarelin—Vomiting—Epirubicin—uterine cancer	0.000346	0.000346	CcSEcCtD
Nafarelin—Diarrhoea—Doxorubicin—uterine cancer	0.000344	0.000344	CcSEcCtD
Nafarelin—Rash—Epirubicin—uterine cancer	0.000343	0.000343	CcSEcCtD
Nafarelin—Dermatitis—Epirubicin—uterine cancer	0.000342	0.000342	CcSEcCtD
Nafarelin—Headache—Epirubicin—uterine cancer	0.000341	0.000341	CcSEcCtD
Nafarelin—Dizziness—Doxorubicin—uterine cancer	0.000333	0.000333	CcSEcCtD
Nafarelin—Nausea—Epirubicin—uterine cancer	0.000323	0.000323	CcSEcCtD
Nafarelin—Vomiting—Doxorubicin—uterine cancer	0.00032	0.00032	CcSEcCtD
Nafarelin—Rash—Doxorubicin—uterine cancer	0.000317	0.000317	CcSEcCtD
Nafarelin—Dermatitis—Doxorubicin—uterine cancer	0.000317	0.000317	CcSEcCtD
Nafarelin—Headache—Doxorubicin—uterine cancer	0.000315	0.000315	CcSEcCtD
Nafarelin—Nausea—Doxorubicin—uterine cancer	0.000299	0.000299	CcSEcCtD
